-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Black Diamond Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
- Black Diamond Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $32,000, a 99% decline year-over-year.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $146,000, a 101% decline from 2024.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $25,547,000, a 64% decline from 2023.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $71,932,000, a 40540% increase from 2022.